Beginning in the fall of 2010, an increasing and alarming number of cases of calves suffering from liver dystrophy were reported in the south of Germany. An epidemiological investigation was carried out by the authors between November 2010 and July 2011, leading to the implication of a commercial dietary supplement as the potential cause for this outbreak. The components of this product were first tested in a cell culture model and two of them (dietary chestnut extract and glycerol monolaurate) showed a cytotoxic effect. The objective of this study was therefore to evaluate the effect of supplemental feeding of both components alone or in combination on liver function in newborn calves on a commercial dairy farm. Ten calves were enrolled in each of the three treatment groups and the control group (group O) following a blocked design. Treatment consisted of supplementation with chestnut extract at 0.02% of birth body mass (BM) (group C), supplementation with glycerol monolaurate at 0.006% of BM (group G) or a combined treatment (group CG) for five consecutive days. The effect of treatments on liver function was evaluated clinically and by measurement of glutamate dehydrogenase (GLDH) and aspartate aminotransferase (AST) activities as well as the determination of the concentrations of glucose, L‐lactate and total bilirubin in serum. There was a significant increase in GLDH and AST activities and a significant decrease in glucose concentration in treatment groups C and CG compared with the control group (p ≤ 0.035), whereas no difference was shown for group G. Survival was significantly decreased in groups C (p = 0.029) and CG (p = 0.001) compared with both group G and the control group. These results suggest that dietary chestnut extract in an amount of 0.02% of BM alone or in combination has a toxic effect on liver function in newborn calves. 相似文献
本研究对翘嘴鲌(Culter alburnus)、团头鲂(Megalobrama amblycephala)及其杂交子一代鲌鲂F1(C.alburnus♀×M.amblycephala♂)、子二代鲌鲂F2(self-crossing of C. alburnus♀×M. amblycephala♂)背部肌肉的营养成分进行了比较分析,并对其营养品质进行了评价与对比。结果显示:鲌鲂F1和F2肌肉的水分含量均显著低于父本团头鲂(P<0.05),粗蛋白含量则显著高于团头鲂(P<0.05),鲌鲂F1的粗脂肪含量显著高于鲌鲂F2和团头鲂(P<0.05)。4种鱼均检测出18种氨基酸,其中,鲌鲂F2的氨基酸总量(TAA)、必需氨基酸(EAA)、呈味氨基酸(DAA)、∑EAA/∑TAA、∑EAA/∑NEAA、氨基酸评分(AAS)、化学评分(CS)及必需氨基酸指数(EAAI)等均不同程度高于亲本及鲌鲂F1。4种鱼均检测出20种以上的脂肪酸,其中,鲌鲂F1的∑PUFA和∑EPA+DHA含量高于双亲,并显著高于鲌鲂F2(P<0.05),∑SFA:∑MUFA:∑PUFA比值为1:1.88:1.02,较双亲及鲌鲂F2更接近人体合理膳食的理想模式。综合分析,相较于双亲,鲌鲂F1具有高脂、高蛋白、高EPA+DHA和均衡的脂肪酸组成等营养价值特点,鲌鲂F2则具有低脂、高蛋白、均衡的氨基酸组成以及最优的食用品质。因此,鲌鲂F1和F2具有不同的营养品质特点,可满足消费者的不同需求,均具有良好开发利用前景。 相似文献
Summary The prevalence of antibodies to various viruses was investigated in a series of serum samples collected from horses in the Netherlands between 1963 and 1966 and from 1972 onwards. Neutralizing antibodies to equine rhinopneumonitis virus, equine arteritis virus and to equine rhinovirus types 1 and 2 were detected in respectively 76%, 14%, 66% and 59% of the equine serum samples tested. The observed incidence of serum samples positive to equine adenovirus in the complement fixation test was 39%. Precipitating antibodies to equine infectious anaemia virus were detected only in serum samples from two horses imported from abroad. Haemagglutination inhibiting antibodies to Myxovirus influenzae A / equi‐1, M. Influenzae A / equi‐2, and Reovirus types 1, 2, and 3 were present in respectively 82%, 50%, 10%, 33% and 3.6% of the serum samples tested. The most frequently observed incidence of antibodies to the various equine respiratory viruses occurred in the groups of horses having repeatedly contact with other horses. 相似文献
Dogs suffering from Golden Retriever muscular dystrophy (GRMD) present symptoms that are similar to human patients with Duchenne muscular dystrophy (DMD). Phenotypic variability is common in both cases and correlates with disease progression and response to therapy. Physical therapy assessment tools were used to study disease progression and assess phenotypic variability in dogs with GRMD. At 5 (T0), 9 (T1), 13 (T2) and 17 (T3) months of age, the physical features, joint ranges of motion (ROM), limb and thorax circumferences, weight and creatine kinase (CK) levels were assessed in 11 dogs with GRMD. Alterations of physical features were higher at 13 months, and different disease progression rates were observed. Passive ROM decreased until 1 year old, which was followed by a decline of elbow and tarsal ROM. Limb and thorax circumferences, which were corrected for body weight, decreased significantly between T0 and T3. These measurements can be used to evaluate disease progression in dogs with GRMD and to help discover new therapies for DMD patients. 相似文献